Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 2,025 | 1,238 | 1,733 | 1,725 | 906 |
| Operating Income | -2,025 | -1,238 | -1,733 | -1,725 | -906 |
| Interest Expense | 5 | 0 | 1 | 2 | 4 |
| Other Income | 0 | -1 | 0 | 0 | 3 |
| Pre-tax Income | -2,029 | -1,239 | -1,733 | -1,727 | -907 |
| Net Income Continuous | -2,029 | -1,239 | -1,733 | -1,727 | -907 |
| Net Income | $-2,029 | $-1,239 | $-1,733 | $-1,727 | $-907 |
| EPS Basic Total Ops | -1.40 | -0.90 | -1.30 | -1.40 | -0.90 |
| EPS Basic Continuous Ops | -1.47 | -0.90 | -1.27 | -1.35 | -0.79 |
| EPS Diluted Total Ops | -1.40 | -0.90 | -1.30 | -1.40 | -0.90 |
| EPS Diluted Continuous Ops | -1.47 | -0.90 | -1.27 | -1.35 | -0.79 |
| EBITDA(a) | $-2,025 | $-1,238 | $-1,733 | $-1,725 | $-906 |